Johnson & JohnsonvsXtant Medical

JNJ and XTNT stock compared: price, dividend, valuation and results, from SEC filings.

XTNT

Xtant Medical Holdings, Inc.

$0.21

Value $29M

-22.22%
XTNT's page

Johnson & Johnson (JNJ) has a market value of $681B and Xtant Medical (XTNT) $29M. Over the last year, with dividends, JNJ moved +47.5% and XTNT -67.7%. Dividend yield: JNJ 1.87%, XTNT none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$681B

    XTNT$29M

    JNJ is 23,171 times XTNT

  • Revenue, 12 months

    JNJ$99.3B

    XTNT$101M

    JNJ is 988 times XTNT

  • Net income, 12 months

    JNJ$16.1B

    XTNT-$16M

  • Operating margin

    JNJ–

    XTNT-16.0%

  • ROIC

    JNJ12.4%

    XTNT-21.5%

    33.9 points apart

  • P/E

    JNJ42.3

    XTNT–

  • Dividend yield

    JNJ1.9%

    XTNT0.0%

    1.9 points apart

  • 5-year return

    JNJ+98.6%

    XTNT-80.2%

    178.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+98.6%

XTNT-80.2%

10020020222023202420252026
Returns by period
PeriodJNJWith dividendsXTNTWith dividends
1 year since November 14, 2025+47.5%Price +44.2%-67.7%Price -67.7%
3 years since November 16, 2023+105.0%+27.0% a yearPrice +88.2%-82.4%-43.9% a yearPrice -82.4%
5 years since November 15, 2021+98.6%+14.7% a yearPrice +72.8%-80.2%-27.7% a yearPrice -80.2%
10 years since November 17, 2016+218.0%+12.3% a yearPrice +142.4%-96.5%-28.5% a yearPrice -96.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonXTNTXtant Medical

Valuation

JNJXTNT
Valuation
Price$282.55$0.21
Market value$681B$29M
Enterprise value (EV)$708B–
P/E42.3–
P/E, 5-year median21.9–
P/B8.40.8
EV/EBIT39.9–
Free cash flow yield3.0%–

Results and growth

JNJXTNT
Results and growth
Revenue, 12 months$99.3B$101M
Net income, 12 months$16.1B-$16M
Free cash flow, 12 months$20.6B-$6.1M
Earnings per share, 12 months$6.59-$0.12
Revenue growth, year on year6.1%14.2%
Revenue growth a year, past+2.7%over 5 years+20.2%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJXTNT
Margins and returns on capital
Gross margin67.6%56.4%
Operating margin–-16.0%
Net margin16.2%-15.9%
ROIC12.4%-21.5%
ROE19.7%-35.2%

Balance sheet

JNJXTNT
Balance sheet
Cash$17.2B$7.8M
Total debt$44.7B–
Net debt / EBITDA1.1–
Interest cover18.0×-6.6×

Dividends and buybacks

JNJXTNT
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.7%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or XTNT

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Xtant Medical?

By market value, Johnson & Johnson ($681B) is about 23,171.2 times Xtant Medical ($29M), at today's prices.

How did JNJ and XTNT stock do over the last 10 years?

Since November 17, 2016, JNJ's price moved +142.4% and XTNT's -96.5%. With dividends: JNJ +218.0% (+12.3% a year), XTNT -96.5% (-28.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or XTNT?

The dividend yield at today's price is 1.87% for Johnson & Johnson and none for Xtant Medical. Over the last twelve months they paid $5.28 and – per share.

Which has the higher profit margins, Johnson & Johnson or Xtant Medical?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and -15.9% for Xtant Medical, and the operating margin – and -16.0%. Revenue was $99.3B and $101M.

Which is the better investment, Johnson & Johnson or Xtant Medical?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.